Over the past quarter century, exposure to ionizing radiation from medical procedures in the U.S. has grown sevenfold, according to the National Council on Radiation Protection and Measurements. CT is a major source.
Over the past quarter century, exposure to ionizing radiation from medical procedures in the U.S. has grown sevenfold, according to the National Council on Radiation Protection and Measurements. CT is a major source.
Managing x-ray dose is the subject of a morning session on opening day, May 19, of the International Symposium on Multidetector-Row CT in San Franciso. There is good reason to be concerned. In 2006, CT accounted for 24% of all radiation exposure in the U.S., twice that of nuclear medicine, three times that of interventional fluoroscopy, and nearly five times more than radiography and diagnostic fluoroscopy, according to a report issued in March by the NCRP.
"CT and nuclear medicine alone contributed three-quarters of the medical radiation exposure of the U.S. population," said Dr. Kenneth R. Kase, senior vice president of NCRP and chair of the scientific committee that produced the report.
In 2006, 67 million CT scans and 18 million nuclear medicine procedures were performed in the U.S., according to the report, Ionizing Radiation Exposure of the Population of the United States.
About half of radiation exposure comes from natural sources found in soil and rocks, radon gas that seeps into homes and other buildings, and radiation from space. A very small amount comes from radiation sources that occur naturally in the human body, according to the NCRP report. Other small contributors of exposure to the U.S. population included consumer products and activities, industrial and research uses, and occupational tasks.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.